Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Evotec, Haplogen in discovery deal for infectious diseases

November 16, 2012 1:52 AM UTC

Evotec AG (Xetra:EVT) and Haplogen GmbH (Vienna, Austria) partnered to discover and develop small molecules against an undisclosed protein to treat viral infectious diseases. The protein was identifie...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article